Lisa Carter-Bawa, PhD, MPH, APRN, explains how nurses can counter lung cancer fatalism by pairing honesty with hope and using teach-back.
|Videos|August 3, 2017
Kerry Nichols on a Nurse Navigator-Led Smoking Cessation Program
Author(s)Kerry Nichols, RN, BSN, OCN
Kerry Nichols, RN, BSN, OCN, explains their nurse navigator-led smoking cessation program.
Advertisement
Kerry Nichols, RN, BSN, OCN, from Billings Clinic Cancer Center, explains their nurse navigator-led smoking cessation program.
Recognizing that providers don't have enough time to fully addressing smoking cessation, nurse navigators at Billings took steps to fill the gap. They adopted a plan of non-judgemental listening and motivational interviews. With the help of a pharmacists, they also discusses medication possibilities such as varenicline (Chantix) and bupropion (Wellbutrin) as well as non-nicotine replacements.
Advertisement
Related to this article
In a 117-patient cohort, 35% waited over 60 days for neoadjuvant chemotherapy, most often because of added workup, second opinions or comorbidities.
Interviews with 15 young women with breast cancer show fertility preservation decisions unfold under time pressure and carry into survivorship.
Among 90 patients with ES-SCLC, all CRS in the outpatient cohort was grade 1, and no patient in any care model was readmitted.
Interim AYA-NAV data show most navigation components reached young patients with cancer as designed, though full sessions lagged during treatment.
As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Care Coordination Faces Neoadjuvant Chemotherapy Delays in MIBC
2
Outpatient Tarlatamab Feasible in Community Oncology, Real-World Data Show
3
Teaching Communication as a Clinical Skill for Breast Cancer Care
4
FDA Approves Amivantamab for Recurrent or Metastatic HNSCC
5